Clinical trial
A Treatment Study for Premenstrual Syndrome (PMS)
NCT00001259 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00001259 |
|---|---|
| Title | A Treatment Study for Premenstrual Syndrome (PMS) |
| Official title | The Treatment of Menstrually-Related Mood Disorders With the Gonadotropin Releasing Hormone (GnRH) Agonist, Depot Leuprolide Acetate (Lupron) |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Premenstrual Syndrome, Menstruation Disturbances |
| Intervention type | Drug |
| Interventions | Leuprolide, Estradiol Patches, Progesterone, Placebo patch, Placebo injection, Placebo suppository |
| Enrollment | 60 |
| Start date | Aug 11, 1992 |
| Primary completion | Feb 6, 2020 |
| Completion | Feb 6, 2020 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 2, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: